Document is current

Any future updates will be listed below

Randomized study of orally administered fluorinated pyrimidines (capecitabine versus S-1) in women with metastatic or recurrent breast cancer: Japan Breast Cancer Research Network 05 Trial

Crossref DOI link: https://doi.org/10.1007/s00280-015-2738-3

Published Online: 2015-04-11

Published Print: 2015-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark